JP2025505258A5 - - Google Patents
Info
- Publication number
- JP2025505258A5 JP2025505258A5 JP2024547657A JP2024547657A JP2025505258A5 JP 2025505258 A5 JP2025505258 A5 JP 2025505258A5 JP 2024547657 A JP2024547657 A JP 2024547657A JP 2024547657 A JP2024547657 A JP 2024547657A JP 2025505258 A5 JP2025505258 A5 JP 2025505258A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- mol
- formulation
- use according
- methoxypeg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156604.5A EP4226949A1 (en) | 2022-02-14 | 2022-02-14 | Preparation for use in a method for the treatment and/or prevention of a disease |
| EP22156604.5 | 2022-02-14 | ||
| PCT/EP2023/053639 WO2023152398A1 (en) | 2022-02-14 | 2023-02-14 | Preparation for use in a method for the treatment and/or prevention of a disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505258A JP2025505258A (ja) | 2025-02-21 |
| JP2025505258A5 true JP2025505258A5 (https=) | 2026-02-18 |
Family
ID=80683166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547657A Pending JP2025505258A (ja) | 2022-02-14 | 2023-02-14 | 疾患の治療方法および／または予防方法に使用するための製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240408014A1 (https=) |
| EP (2) | EP4226949A1 (https=) |
| JP (1) | JP2025505258A (https=) |
| KR (1) | KR20240149887A (https=) |
| CN (1) | CN118695875A (https=) |
| AU (1) | AU2023217931A1 (https=) |
| CA (1) | CA3243105A1 (https=) |
| WO (1) | WO2023152398A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4681739A1 (en) | 2024-07-19 | 2026-01-21 | PROVIREX Genome Editing Therapies GmbH | Lipid nanoparticles for direct delivery |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011119058A2 (en) * | 2010-03-22 | 2011-09-29 | Universidade De Coimbra | F3-peptide targeted lipid-based nanoparticles useful for the treatment of angiogenesis-dependent diseases |
| JP2018509387A (ja) * | 2015-01-21 | 2018-04-05 | フェーズアールエックス インコーポレイテッド | 細胞に治療および診断剤を送達するための方法、組成物、ならびにシステム |
| US20180200186A1 (en) * | 2015-07-09 | 2018-07-19 | Insmed Incorporated | Compositions and methods for treating lung diseases and lung injury |
| EP3562510A4 (en) * | 2016-12-30 | 2021-01-06 | Genevant Sciences GmbH | BRANCHED PEG MOLECULES AND ASSOCIATED COMPOSITIONS AND PROCEDURES |
-
2022
- 2022-02-14 EP EP22156604.5A patent/EP4226949A1/en active Pending
-
2023
- 2023-02-14 JP JP2024547657A patent/JP2025505258A/ja active Pending
- 2023-02-14 CN CN202380021541.XA patent/CN118695875A/zh active Pending
- 2023-02-14 EP EP23704174.4A patent/EP4479096A1/en active Pending
- 2023-02-14 CA CA3243105A patent/CA3243105A1/en active Pending
- 2023-02-14 KR KR1020247025588A patent/KR20240149887A/ko active Pending
- 2023-02-14 AU AU2023217931A patent/AU2023217931A1/en active Pending
- 2023-02-14 WO PCT/EP2023/053639 patent/WO2023152398A1/en not_active Ceased
-
2024
- 2024-08-13 US US18/802,912 patent/US20240408014A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU705644B2 (en) | Liposomal oligonucleotide compositions | |
| JP7370344B2 (ja) | 筋ジストロフィーに対するエクソンスキッピングオリゴマーコンジュゲート | |
| US20240218399A1 (en) | Lipid compounds and lipid nanoparticle compositions | |
| JP6038017B2 (ja) | 核酸を含む逆ミセル系及びその使用 | |
| JP2011516094A5 (https=) | ||
| US20240350662A1 (en) | Systems and methods for nucleic acid expression in vivo | |
| CA2748520A1 (en) | Pharmaceutical composition containing an anionic drug, and a production method therefor | |
| Ita | Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides-advances and hurdles | |
| JP2025505258A5 (https=) | ||
| CA3266086A1 (en) | IONIZABLE LIPIDS, LIPID NANOPARTICLES AND THEIR USES | |
| JP6986563B2 (ja) | ｂｃｌ−２を抑制するアンチセンスオリゴヌクレオチドの脂質ナノ粒子及びその調製方法 | |
| US20240408014A1 (en) | Preparation for use in a method for the treatment and/or prevention of a disease | |
| KR20240107033A (ko) | 양이온성 분자 수송체 및 mRNA의 이온복합체를 포함하는 백신 조성물 | |
| KR20240072931A (ko) | 히스티딘을 포함하는 지질 나노입자 및 그 제조방법 | |
| JP2015143263A (ja) | 製薬組成物を製造するためのｌ−リボザイムの使用、ｌ−リボザイムを含む製薬組成物およびｌ−リボザイムを含む製薬組成物を製造するための方法 | |
| WO2023208076A1 (zh) | 一种高转染效率的阳离子脂质纳米粒及其制备方法 | |
| KR20250092049A (ko) | mRNA/LNP 백신의 면역원성 향상용 지질 | |
| WO1998009633A2 (en) | Pharmaceutical compositions | |
| WO2024199144A1 (en) | Novel reagent for mitigating lnp toxicity | |
| CN121197094A (zh) | 一种花生四烯酸脂质纳米递药系统 | |
| EP4124345A1 (en) | Nanoparticles for muscle delivery | |
| JP2025532969A (ja) | エクソンスキッピングのためのアンチセンスオリゴヌクレオチド、組成物および医薬製剤 | |
| CN121401237A (zh) | 一种花生四烯酸脂质纳米递药系统的制备方法 | |
| CN118576563A (zh) | 一种适用于肌注给药的核酸-脂质纳米颗粒制剂及其使用方法 | |
| WO2022207736A1 (fr) | Formulation pour la délivrance d'arn messager |